INDEPENDENT AUDITORS' CONSENT
    
 
   
The Board of Directors
Atlantic Pharmaceuticals, Inc.:
    
 
   
    We consent to the use of our reports incorporated herein by reference and to
the reference to our firm under the heading "Experts" in the prospectus.
    
 
   
    Our report dated March 11, 1997, contains an explanatory paragraph that
states that the Company has suffered recurring losses from operations and has
limited capital resources, which raise substantial doubt about its ability to
continue as a going concern. The consolidated financial statements do not
include any adjustments that might result from the outcome of that uncertainty.
    
 
   
                                          /s/ KPMG PEAT MARWICK LLP
    
 
Raleigh, North Carolina
October 24, 1997